These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7934234)
1. [The cost of tests and their informational content]. Ridanović Z; Masić I Med Arh; 1993; 47(3-4):97-9. PubMed ID: 7934234 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic information as a commodity. Johnson HA Clin Chem; 1995 May; 41(5):781-4; discussion 813-6. PubMed ID: 7729067 [TBL] [Abstract][Full Text] [Related]
5. Optimal test strategy in the case of two tests and one disease. Ament A; Hasman A Int J Biomed Comput; 1993 Nov; 33(3-4):179-97. PubMed ID: 8307651 [TBL] [Abstract][Full Text] [Related]
6. The informative content of diagnostic tests: an economic analysis. Eeckhoudt LR; Lebrun TC; Sailly JC Soc Sci Med; 1984; 18(10):873-80. PubMed ID: 6427932 [TBL] [Abstract][Full Text] [Related]
8. Predictive value and efficiency of hematology data. Galen RS Blood Cells; 1980; 6(2):185-97. PubMed ID: 6769520 [TBL] [Abstract][Full Text] [Related]
9. Improving laboratory monitoring of medications: an economic analysis alongside a clinical trial. Smith DH; Feldstein AC; Perrin NA; Yang X; Rix MM; Raebel MA; Magid DJ; Simon SR; Soumerai SB Am J Manag Care; 2009 May; 15(5):281-9. PubMed ID: 19435396 [TBL] [Abstract][Full Text] [Related]
10. Cost and effectiveness of clinical investigation: the state of the art. Clarke RM; Mason B; Leeder SR Aust N Z J Med; 1980 Oct; 10(5):572-80. PubMed ID: 6781460 [TBL] [Abstract][Full Text] [Related]
11. Activity-based costing methodology as tool for costing in hematopathology laboratory. Gujral S; Dongre K; Bhindare S; Subramanian PG; Narayan H; Mahajan A; Batura R; Hingnekar C; Chabbria M; Nair CN Indian J Pathol Microbiol; 2010; 53(1):68-74. PubMed ID: 20090226 [TBL] [Abstract][Full Text] [Related]
12. The need for systematic evaluations of diagnostic tests. Jani IV Clin Infect Dis; 2010 Sep; 51(5):609-10. PubMed ID: 20649435 [No Abstract] [Full Text] [Related]
13. A method for determining costs associated with laboratory error. Cavenaugh EL Am J Public Health; 1981 Aug; 71(8):831-4. PubMed ID: 6789688 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis. Hamers RL; Sawyer AW; Tuohy M; Stevens WS; Rinke de Wit TF; Hill AM; AIDS; 2012 Aug; 26(13):1663-72. PubMed ID: 22695297 [TBL] [Abstract][Full Text] [Related]
16. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach. Elbasha EH Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661 [TBL] [Abstract][Full Text] [Related]
17. When do new biomarkers make economic sense? Scott MG Scand J Clin Lab Invest Suppl; 2010; 242():90-5. PubMed ID: 20515285 [TBL] [Abstract][Full Text] [Related]
18. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland. Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681 [TBL] [Abstract][Full Text] [Related]
19. Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis. D'Souza LS; Payette MJ J Am Acad Dermatol; 2015 Apr; 72(4):589-98. PubMed ID: 25631851 [TBL] [Abstract][Full Text] [Related]
20. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results. Hickner J; Thompson PJ; Wilkinson T; Epner P; Sheehan M; Pollock AM; Lee J; Duke CC; Jackson BR; Taylor JR J Am Board Fam Med; 2014; 27(2):268-74. PubMed ID: 24610189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]